Globe Newswire11.13.18
Integra LifeSciences Holdings Corporation has appointed Eric Schwartz as corporate vice president, general counsel, and secretary.
“I am pleased to welcome Eric as our new general counsel and latest member of the executive leadership team,” said Peter Arduini, president and CEO of Integra LifeSciences. “His extensive background and leadership experience in life sciences, as well as his global knowledge in mergers and acquisitions, regulatory, and providing board and corporate governance support make him an exceptional addition to Integra.”
Most recently, Schwartz was the general counsel at Globus Medical, a global orthopedic medical devices company, where he led several strategic transactions, including the largest acquisition in its company history, and led a cross-functional team responsible for integrating operations in over 20 countries. Before this role, Schwartz was the chief operating officer and chief legal officer of CardioVIP, a technology-enabled clinical provider assisting physicians with comprehensive disease management for their patients with cardiovascular disease. Schwartz’s experience also includes roles of increasing responsibility in the law departments at Johnson and Johnson, Animas Corporation and Cable & Wireless America. Earlier in his career, Schwartz was in private practice at Skadden, Arps, Slate, Meagher & Flom LLP and Dechert LLP.
Schwartz received his bachelor’s degree in english and his law degree from the University of Virginia. He also has a master’s degree in business from the Wharton School of the University of Pennsylvania.
Integra LifeSciences is a global developer of regenerative technologies, neurosurgical, and extremity orthopedic solutions. Integra offers a portfolio of brands that include AmnioExcel, Bactiseal, Cadence, Certas, Codman, CUSA, DuraGen, DuraSeal, ICP Express, Integra, MediHoney, MicroFrance, PriMatrix, Salto Talaris, SurgiMend, TCC-EZ, Titan, and VersaTru. The company is based in Plainsboro, N.J.
“I am pleased to welcome Eric as our new general counsel and latest member of the executive leadership team,” said Peter Arduini, president and CEO of Integra LifeSciences. “His extensive background and leadership experience in life sciences, as well as his global knowledge in mergers and acquisitions, regulatory, and providing board and corporate governance support make him an exceptional addition to Integra.”
Most recently, Schwartz was the general counsel at Globus Medical, a global orthopedic medical devices company, where he led several strategic transactions, including the largest acquisition in its company history, and led a cross-functional team responsible for integrating operations in over 20 countries. Before this role, Schwartz was the chief operating officer and chief legal officer of CardioVIP, a technology-enabled clinical provider assisting physicians with comprehensive disease management for their patients with cardiovascular disease. Schwartz’s experience also includes roles of increasing responsibility in the law departments at Johnson and Johnson, Animas Corporation and Cable & Wireless America. Earlier in his career, Schwartz was in private practice at Skadden, Arps, Slate, Meagher & Flom LLP and Dechert LLP.
Schwartz received his bachelor’s degree in english and his law degree from the University of Virginia. He also has a master’s degree in business from the Wharton School of the University of Pennsylvania.
Integra LifeSciences is a global developer of regenerative technologies, neurosurgical, and extremity orthopedic solutions. Integra offers a portfolio of brands that include AmnioExcel, Bactiseal, Cadence, Certas, Codman, CUSA, DuraGen, DuraSeal, ICP Express, Integra, MediHoney, MicroFrance, PriMatrix, Salto Talaris, SurgiMend, TCC-EZ, Titan, and VersaTru. The company is based in Plainsboro, N.J.